Cite
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.
MLA
McChalicher, Christopher W. J., et al. “Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.” Journal of Infectious Diseases, vol. 228, no. 10, Nov. 2023, pp. 1452–55. EBSCOhost, https://doi.org/10.1093/infdis/jiad298.
APA
McChalicher, C. W. J., Lombardo, M.-J., Khanna, S., McKenzie, G. J., Halvorsen, E. M., Almomani, S., Schuster, B., Hasson, B. R., McGovern, B. H., Ege, D. S., & Auniņš, J. G. (2023). Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool. Journal of Infectious Diseases, 228(10), 1452–1455. https://doi.org/10.1093/infdis/jiad298
Chicago
McChalicher, Christopher W J, Mary-Jane Lombardo, Sahil Khanna, Gregory J McKenzie, Elizabeth M Halvorsen, Sanabel Almomani, Brian Schuster, et al. 2023. “Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.” Journal of Infectious Diseases 228 (10): 1452–55. doi:10.1093/infdis/jiad298.